Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Xiaflex Market Growth Potential: How Will Market Size Shift Through 2030?
Historical growth has been driven by a rise in the occurrence of Dupuytren’s contracture, enhanced recognition of non-surgical treatment options, the wider uptake of specialty biologics, the presence of skilled healthcare providers, and increasing receptiveness to injectable treatments.
Anticipated growth during the forecast period stems from a rising need for biologic therapies administered outside hospital settings, a heightened emphasis on decreasing the reliance on surgical procedures, the broadening application of individualized medical strategies, an expanding elderly demographic, and ongoing advancements in treatments specifically targeting collagen.
Key developments projected for the forecast period encompass a greater uptake of enzyme-based non-surgical treatments, an escalating preference for treatment methods that are less invasive, an intensifying concentration on biologic injectables designed for specific targets, the broadening availability of specialized therapies managed by physicians, and a strengthened focus on crafting treatment plans tailored to individual patients.
Get A Free Sample Report With In-Depth Market Insights:
Xiaflex Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of Peyronie’s disease is projected to boost the expansion of the xiaflex market in the future. Peyronie’s disease is a condition affecting connective tissue, marked by the formation of fibrous plaques within the penis, leading to curvature and pain. Its increase is influenced by elements like aging, genetic predispositions, and damage to tissues resulting from injury. XIAFLEX serves to dissolve these fibrous plaques in Peyronie’s disease, thereby enhancing penile curvature and functionality. As an illustration, data released in February 2023 by The Urology Care Foundation, the US-based organization of the American Urological Association focused on improving urological care through research, education, and community efforts, indicated that roughly 4 out of 100 men aged 40 to 70 suffer from Peyronie’s disease. Further findings suggest that approximately 0.5% of adult American men receive a diagnosis of Peyronie’s disease. Consequently, the growing occurrence of Peyronie’s disease is anticipated to stimulate the expansion of the xiaflex market.
Xiaflex Market Segment Landscape And Growth Outlook
The xiaflex market covered in this report is segmented –
1) By Indication: Dupuytren’s Contracture, Peyronie’s Disease, Other Indications
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End User: Adult, Geriatric
Xiaflex Market Growth Trends Reshaping The Competitive Landscape
The main trend in the xiaflex market centers on investigating alternative treatment methods for resistant conditions, such as focused research into xiaflex’s role in surgery and expanding its therapeutic applications to address unmet needs in hand and connective tissue disorders. Xiaflex is being examined for its potential benefits in surgical contexts, especially for reducing the necessity of invasive procedures and improving patient recuperation. For example, in May 2024, Endo International Plc, a US-based pharmaceutical company, revealed the presentation of new data concerning Peyronie’s disease and XIAFLEX at the American Urological Association’s (AUA) annual meeting. These studies, supported by Endo’s investigator-initiated research grants, concentrated on evaluating XIAFLEX against surgery and exploring new treatment protocols for patients who had not responded to previous therapies. The company’s ongoing dedication to advancing XIAFLEX’s clinical outcomes reflects its commitment to enhancing patient care and broadening its potential therapeutic applications.
Xiaflex Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the xiaflex market are Endo Inc.
View The Full Xiaflex Market Report:
Xiaflex Market Regional Analysis And Top Geography
North America was the largest region in the xiaflex market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xiaflex market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
